{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:07:31Z","timestamp":1784304451925,"version":"3.55.0"},"reference-count":53,"publisher":"Wiley","issue":"13","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Up\u2010to\u2010date tumor markers are considered more helpful in the evaluation of treatment response and prognostication than in diagnosis. Identification of a valid biomarker to help clinical management of hepatocellular carcinoma (HCC) is still a challenge, especially in alpha\u2010fetoprotein (AFP) negative HCC. This study evaluated the efficacy of serum Midkine in HCC treatment response and prognostication as well as its association with clinical pathological features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The enzyme\u2010linked immunosorbent assay (ELISA) was used to analyze the serum (soluble) Midkine levels in patients with benign and malignant liver disease and healthy subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum Midkine levels in HCC, hepatic cholangiocarcinoma (HC), chronic hepatitis B (CHB), and decompensated hepatic cirrhosis (DHC) patients were significantly higher than in healthy subjects and patients with benign hepatic tumors, with HCC being the highest. Serum Midkine levels were associated with patients' clinical pathologic features such as tumor size, ascites, high Child\u2010Pugh and BCLC stages, and advanced clinical stages. Serum Midkine was helpful in characterizing the AFP negative HCC patients. A model has been created using univariate and multivariate regression analysis of biomarkers in predicting HCC, which showed that Midkine was one of the key predictive factors in AFP negative HCC. Midkine levels as a parameter for treatment response evaluation and disease progression\/prognostication are comparable to computed tomography scan (CT) and magnetic resonance imaging (MRI), especially in non\u2010surgical treatment patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum Midkine levels could be used as a parameter for evaluation of treatment efficacy and prognostication of HCC, especially in AFP\u2010negative HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jcla.70255","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:39:41Z","timestamp":1779723581000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication"],"prefix":"10.1002","volume":"40","author":[{"given":"Yanfang","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine The People's Hospital of Guangxi Zhuang Autonomous Region  Nanning Guangxi China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuwei","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The People's Hospital of Guangxi Zhuang Autonomous Region  Nanning Guangxi China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The Third People's Hospital of Nanning  Nanning Guangxi China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5608-482X","authenticated-orcid":false,"given":"Liejun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine The People's Hospital of Guangxi Zhuang Autonomous Region  Nanning Guangxi China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"e_1_2_14_2_1","unstructured":"\u201cKey Statistics About Liver Cancer \u201dhttps:\/\/www.cancer.org\/cancer\/types\/liver\u2010cancer\/about\/what\u2010is\u2010key\u2010statistics.html."},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889\u2010025\u201022026\u20106"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885\u2010024\u201012334\u20102"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084188"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.01.014"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000343842"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100781"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2024.00018"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.15557\/JoU.2012.0032"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.812832"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330\u2010018\u20105641\u20106"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876\u2010022\u201002279\u2010w"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.4172\/clinical\u2010practice.1000393"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12253\u2010019\u201000585\u20105"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027673"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5087643"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885\u2010017\u20103609\u20106"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388\u2010019\u20101124\u20108"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.09.002"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12601"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.4274\/ejbh.galenos.2024.2024\u20104\u20107"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12014\u2010017\u20109169\u20106"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756\u20109966\u201029\u201062"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092402"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010021\u201094272\u20108"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.12226"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349\u20107006.2005.00001.x"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells13020136"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2019.09.002"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.17691\/stm2021.13.1.03"},{"key":"e_1_2_14_32_1","first-page":"15","article-title":"Status of Serum Alpha Feto\u2010Protein (AFP) and Midkine (MDK) Levels in Patients With Hepatocellular Carcinoma","volume":"2","author":"Haque S.","year":"2015","journal-title":"Journal of Basic Research in Medical Sciences"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.2478\/rjim\u20102022\u20100014"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15340"},{"key":"e_1_2_14_35_1","first-page":"419","article-title":"New Genetic Markers for Diagnosis of Hepatitis C Related Hepatocellular Carcinoma in Egyptian Patients","volume":"22","author":"Saad Y.","year":"2013","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010020\u201062051\u20106"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.CCR\u201012\u20103363"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025112"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jimed.2020.10.009"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.19082\/3492"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2018.19.6.1503"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPWT70XOVXSVGE"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.21608\/aeji.2017.10599"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43046\u2010023\u201000170\u20107"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155800"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000317"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2022.00013"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030949"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.EPI\u201018\u20100281"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.1108\/SR\u201002\u20102020\u20100030"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2024.05.001"},{"key":"e_1_2_14_52_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2024.14416"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm\u20102022\u20101098"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101391"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.70255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcla.70255","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.70255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:40:36Z","timestamp":1784302836000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.70255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":53,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/jcla.70255"],"URL":"https:\/\/doi.org\/10.1002\/jcla.70255","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"value":"0887-8013","type":"print"},{"value":"1098-2825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"2026-02-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70255"}}